Client Overview
A Dubai-based healthcare company sought Regulatory support for the successful registration of Paclitaxel Phares, a pharmaceutical product intended for the Saudi Arabian market. The client required expert guidance in navigating Saudi FDA (SFDA) registration requirements, dossier compilation, Regulatory documentation, submission management, and compliance with local pharmaceutical regulations to facilitate timely product approval and market access.
Background
As part of its Middle East expansion strategy, the client aimed to register Paclitaxel Phares in Saudi Arabia. However, the registration process required a comprehensive understanding of SFDA Regulatory requirements, pharmaceutical product registration procedures, dossier preparation standards, and country-specific compliance obligations.
The company needed an experienced Regulatory partner capable of managing registration activities, preparing compliant submission dossiers, addressing Regulatory requirements, and supporting interactions throughout the approval process.
Services in Scope
SFDA Product Registration Support
Regulatory Strategy and Registration Planning
CTD Dossier Preparation and Compilation
Gap Analysis and Documentation Review
Regulatory Submission Management
Health Authority Query Management
Registration Lifecycle Support
Regulatory Compliance and Quality Review
Challenge
Complex SFDA Regulatory Requirements The client needed to navigate evolving Saudi FDA regulations and ensure compliance with country-specific pharmaceutical registration requirements.
Dossier Compilation and Documentation Readiness Preparing a complete and compliant registration dossier required careful review, compilation, and alignment with SFDA submission expectations.
Regulatory Submission Coordination Managing submission timelines, documentation requirements, and Regulatory communications required specialized expertise and close coordination.
Market Entry Timelines The client sought timely registration approval to support product commercialization and market expansion within Saudi Arabia.
Solution
1
Regulatory Gap Assessment
Conducted a detailed review of available documentation and identified gaps against SFDA registration requirements to ensure submission readiness.
2
Dossier Preparation and Compilation
Prepared and compiled the registration dossier in accordance with Saudi FDA pharmaceutical registration guidelines, ensuring completeness and compliance.
3
Submission Management
Managed end-to-end submission activities, including documentation review, publishing, compilation, and submission coordination.
4
Regulatory Compliance Support
Provided continuous Regulatory guidance to ensure alignment with SFDA requirements and address potential compliance risks.
5
Health Authority Support
Supported communication and coordination related to Health Authority requirements, facilitating a smoother registration process.
Impact
Freyr's support enabled the client to successfully register Paclitaxel Phares in Saudi Arabia while improving Regulatory efficiency, submission quality, and compliance readiness.
Regulatory Excellence
- Achieved successful SFDA product registration
- Ensured compliance with Saudi pharmaceutical Regulatory requirements
- Enhanced dossier quality and submission readiness
- Strengthened Regulatory governance and documentation standards
Faster Registration Process
- Streamlined registration planning and submission execution
- Improved coordination of Regulatory activities
- Accelerated approval timelines and market access readiness
Operational Efficiency
- Reduced the burden on internal Regulatory teams
- Improved documentation management and submission workflows
- Enabled efficient management of Regulatory requirements
Business Value
- Supported successful entry into the Saudi Arabian pharmaceutical market
- Expanded access to a key Middle East healthcare market
- Strengthened the client's Regulatory and commercialization strategy
- Enabled faster realization of market growth opportunities
